Desipramine Hydrochloride Tablets, USP, 50 mg, 100 count bottle (NDC 23155-580-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816.
Published November 5, 2025 · Recall initiated: October 6, 2025
Summary
FDA records drug Class II recall D-0109-2026, published November 5, 2025 and initiated October 6, 2025. Recalling firm: Heritage Pharmaceuticals Inc; Status: Ongoing; Reported quantity: 5880 bottles.; Lot: Lot#:18036713, Exp Date: 08/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
What to do
Voluntary: Firm initiated · Letter
Get an email if DESIPRAMINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DESIPRAMINE HYDROCHLORIDE
- Manufacturer
- Heritage Pharmaceuticals Inc
- Distributor
- U.S. Nationwide.
- UPC
- 0323155579017
- Lot
- Lot#:18036713, Exp Date: 08/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADesipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by:November 5, 2025
- FDADesipramine Hydrochloride Tablets, USP, 150 mg, 50 count bottle (NDC 23155-583-25), Rx only, Manufactured by:November 5, 2025
- FDADesipramine Hydrochloride Tablets, USP, 10 mg, 100 - count bottle (NDC 23155-578-01), Rx only, ManufacturedNovember 5, 2025
- FDADesipramine Hydrochloride Tablets, USP, 100 mg, 100 count bottle (NDC 23155-582-01), Rx only, Manufactured by:November 5, 2025
- FDADesipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by:November 5, 2025
- FDAPrazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., NorthNovember 5, 2025
Questions about this recall
Was Desipramine Hydrochloride Tablets, USP, 50 mg, 100 count bottle (NDC 23155-580-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. recalled?
Yes. FDA published recall D-0109-2026 on November 5, 2025. Reported hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DESIPRAMINE HYDROCHLORIDE. UPC: 0323155579017.